How many employees does Caviarlieri have?

As of Aug 31, 2026, the latest employee count at Caviarlieri is 1.

Where does Caviarlieri rank among its competitors?

Caviarlieri ranks 3666th amongst 4428 active competitors, of which 125 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ipsen, which secured $618K in Dec, 2023.

Who are the top competitors of Caviarlieri?

Caviarlieri's top competitors include Abbott, WuXi AppTec and Precision Medicine Group. Among them, Ipsen secured the most recent funding round in December, 2023.

Caviarlieri - 2026 Company Profile & Competitors

Company Details

Website: www.swisscaviarlieri.com/
Social

Key Metrics

Stage

Unfunded

Ranked

3666^th among 4428 active competitors

Employee Count

1 as on Aug 31, 2026

Similar Companies

Abbott & 3577 more

View Caviarlieri's full profile

Caviarlieri has not raised any funding rounds yet.

Caviarlieri's employee count trend

Caviarlieri has 1 employees as of Aug 26. Here is Caviarlieri's employee count trend over the years:

Uncover Caviarlieri's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Caviarlieri include Abbott, WuXi AppTec and Precision Medicine Group. Here is the list of Top 10 competitors of Caviarlieri, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abbott 1888, Libertyville (United States), Public	Developer of medical devices, generic pharmaceuticals, and nutrition products	-	MSN Laboratories, Digital Pharma Lab & 12 others	76/100
2nd	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	75/100
3rd	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Oak Investment Partners & 7 others	72/100
4th	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	JPMorgan Chase, Ampersand Capital & 4 others	64/100
5th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, PAI Partners & 2 others	63/100
6th	Neolife 1958, Fremont (United States), Unfunded	Provider of whole food nutritional supplements	-	-	62/100
7th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
8th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
9th	Roquette 1933, Lestrem (France), Funding Raised	CDMO focused on manufacturing of plant based pharma, nutraceuticals, cosmetics, and other products	-	Europa	60/100
10th	Herbalife 1980, Los Angeles (United States), Public	Manufacturer of nutritional supplement products for multiple therapeutic conditions	-	Alua Capital Management, Golden Gate Capital ... & 2 others	60/100
3666th	Caviarlieri Unfunded	-	-	-	16/100